Watchlist Price Alert

Verve Therapeutics Inc. (VERV)

NASDAQ: VERV · Real-Time Price · USD

11.32

5.05 (80.54%)

At close: Jun 17, 2025, 3:41 PM

Verve Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-198.71M	-200.07M	-157.39M	-120.31M	-45.7M	-19.3M
Depreciation & Amortization	6.75M	5.46M	2.8M	1.53M	1.33M	106K
Stock-Based Compensation	43.26M	35.12M	22.48M	7.07M	850K	446K
Other Working Capital	-3.07M	19.68M	13.6M	-9.74M	4.54M	926K
Other Non-Cash Items	-6.73M	-7.75M	1.39M	35.23M	5.24M	8.71M
Deferred Income Tax	n/a	n/a	n/a	1.51M	380K	-72K
Change in Working Capital	-2.26M	17.7M	8.38M	-2.91M	2.64M	2.66M
Operating Cash Flow	-157.69M	-149.55M	-122.33M	-77.88M	-35.27M	-7.44M
Capital Expenditures	-3.74M	-9.28M	-13.23M	-4.36M	-3.42M	-1.86M
Cash Acquisitions	n/a	n/a	142.72M	234.74M	47.7M	10.9M
Purchase of Investments	-424M	-517.14M	-479.4M	-371.49M	-98.48M	-22M
Sales Maturities Of Investments	502.61M	554.11M	336.68M	136.75M	50.78M	11.1M
Other Investing Acitivies	n/a	n/a	-142.72M	-234.74M	-47.7M	-10.9M
Investing Cash Flow	74.88M	27.69M	-155.96M	-239.1M	-51.13M	-12.76M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.46M	2.12M	2.46M	-1.88M	11K	-86K
Financial Cash Flow	49.2M	212.58M	328.96M	377.09M	92.63M	17.95M
Net Cash Flow	-33.62M	90.72M	50.67M	60.11M	6.24M	-2.25M
Free Cash Flow	-161.43M	-158.83M	-135.56M	-82.24M	-38.69M	-9.3M